251. Structure of the glucagon receptor in complex with a glucagon analogue
- Author
-
Anna Qiao, Huaiyu Yang, Antao Dai, Cuiying Yi, Hualiang Jiang, Jesper Lau, Ming-Wei Wang, Ned Van Eps, Steffen Reedtz-Runge, Hui Zhang, Raymond C. Stevens, Klaus Stensgaard Frederiksen, Linlin Yang, Michael A. Hanson, Can Cao, Lingli He, Oliver P. Ernst, Dehua Yang, Beili Wu, Haonan Zhang, Qiang Zhao, and Xiaoqing Cai
- Subjects
0301 basic medicine ,Models, Molecular ,Protein Conformation ,Peptide binding ,Peptide ,Crystallography, X-Ray ,Ligands ,03 medical and health sciences ,0302 clinical medicine ,Protein structure ,Receptors, Glucagon ,Glucose homeostasis ,Humans ,Receptor ,Glucagon-like peptide 1 receptor ,G protein-coupled receptor ,chemistry.chemical_classification ,Multidisciplinary ,Glucagon ,Drug Partial Agonism ,030104 developmental biology ,chemistry ,Biophysics ,Glucagon receptor ,030217 neurology & neurosurgery ,Protein Binding - Abstract
The crystal structure of the full-length glucagon receptor in complex with a glucagon analogue NNC1702 reveals how the peptide ligand interacts with its target and shows the conformational changes required for receptor activation. The glucagon receptor is a class B G-protein-coupled receptor with an important role in glucose homeostasis. Activation of this receptor triggers the release of glucose, making it an important target for the treatment of type 2 diabetes. Beili Wu and colleagues now report the crystal structure of the full-length glucagon receptor bound to a glucagon analogue and a partial agonist, NNC1702. The 3.0 A resolution of the structure provides key insights into how the peptide ligand interacts with its target and the conformational changes involved in the initial stages of activation. The structural data is reinforced by using double electron–electron resonance (DEER) spectroscopy, which demonstrates the extent of rearrangement that is involved in accommodating the glucagon analogue. Class B G-protein-coupled receptors (GPCRs), which consist of an extracellular domain (ECD) and a transmembrane domain (TMD), respond to secretin peptides to play a key part in hormonal homeostasis, and are important therapeutic targets for a variety of diseases1,2,3,4,5,6,7,8. Previous work9,10,11 has suggested that peptide ligands bind to class B GPCRs according to a two-domain binding model, in which the C-terminal region of the peptide targets the ECD and the N-terminal region of the peptide binds to the TMD binding pocket. Recently, three structures of class B GPCRs in complex with peptide ligands have been solved12,13,14. These structures provide essential insights into peptide ligand recognition by class B GPCRs. However, owing to resolution limitations, the specific molecular interactions for peptide binding to class B GPCRs remain ambiguous. Moreover, these previously solved structures have different ECD conformations relative to the TMD, which introduces questions regarding inter-domain conformational flexibility and the changes required for receptor activation. Here we report the 3.0 A-resolution crystal structure of the full-length human glucagon receptor (GCGR) in complex with a glucagon analogue and partial agonist, NNC1702. This structure provides molecular details of the interactions between GCGR and the peptide ligand. It reveals a marked change in the relative orientation between the ECD and TMD of GCGR compared to the previously solved structure of the inactive GCGR–NNC0640–mAb1 complex. Notably, the stalk region and the first extracellular loop undergo major conformational changes in secondary structure during peptide binding, forming key interactions with the peptide. We further propose a dual-binding-site trigger model for GCGR activation—which requires conformational changes of the stalk, first extracellular loop and TMD—that extends our understanding of the previously established two-domain peptide-binding model of class B GPCRs.
- Published
- 2017